351 Views | 322 Downloads
Correspondence: Dr. Aasef G. Shaikh, Department of Neurology, Case Western Reserve Un iversity, 11100 Euclid Avenue, Cleveland, OH44022; E-mail: aasefshaikh@gmail.com
Author Contributions: AS conceptualized the manuscript, collected, analyzed data, wrote and edited manuscript.
JJ and SF collected data and edited manuscript.
Disclosures: Stewart A. Factor reports honoraria from Neurocrine, Lundbeck, Auspex/Teva, Avanir, Cynapsus Therapeutics, Adamas, and UCB, grants from Ipsen, Medtronics, Teva, US World Meds, Pharm-Olam, Cynapsus Therapeutics, Solstice, Vaccinex, the CHDI Foundation, the Michael J. Fox Foundation, and the National Institutes of Health; and royalties from Demos, Blackwell Futura (for textbooks), and UpToDate.
Jorge L. Juncos reports support from the National Institutes of Health, the National Institute of Child Health and Development, the Michael J. Fox Foundation, Adamas, and World Meds and support for research through Emory University
Aasef G. Shaikh was supported by a Dystonia Medical Research Foundation Clinical Fellowship Award and a Dystonia Coalition/Dystonia Medical Research Foundation Career Development Award (NIH U54 TR001456).
© 2017 International Parkinson and Movement Disorder Society